Dergiler / Eurasian Journal of Medicine / 2019 / Cilt: 51 - Sayı: 1

Complete Heart Block due to Octreotide Infusion in Patient with Cryptogenic Cirrhosis

Sayfa
95–97
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

He was discharged upon recommendation.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:A 62-year-old man was admitted to the emergency department (ED) with the complaint of intense hematemesis.
📊
Temel Bulgular & Veri:He was admitted to intensive care unit because of acute esophageal variceal hemorrhage.
💡
Sonuç & Katkı:He was discharged upon recommendation.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

A 62-year-old man was admitted to the emergency department (ED) with the complaint of intense hematemesis. He was admitted to intensive care unit because of acute esophageal variceal hemorrhage. He underwent sclerotherapy followed by a slow infusion of intravenous octreotide. Complete heart block occured in the patient during octreotide infusion and infusion was stopped. Temporary pacemaker was placed in the patient’s heart. Normal sinus rhythm was observed in the follow up one day later and the pacemaker was removed from patient. He was discharged upon recommendation.

🔖

Bu Makaleye Atıf Yap

SÜMBÜL, H. E., İÇEN, Y. K., URGUN, O. D., KOÇ, M. (2022). Complete Heart Block due to Octreotide Infusion in Patient with Cryptogenic Cirrhosis. Eurasian Journal of Medicine, Cilt: 51 - Sayı: 1, 95–97. https://ajindex.com/articles/508962

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Shah HA, Mumtaz K, Jafri W, et al. Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastro-oesophageal variceal hemorrhage. J Ayub Med Coll Abbottabad 2005; 17: 10-4
  2. Chanson P, Timsit J, Masquet C, et al. Cardiovascular effects of the somatostatin analog octreotide in acromegaly. Ann Intern Med 1990; 113: 921-5. [CrossRef] 3. Dilger JA, Rho EH, Que FG, Sprung J. Octreotide induced bradycardia and heart block during surgicalresection of a carcinoid tumor. Anesth Analg 2004; 98: 318-20. [CrossRef] 4. Sàbat M, Guarner C, Soriano G, et al. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites. Dig Dis Sci 1998; 43: 2184-9. [CrossRef] 5. Eriksson LS, Brundin T, Soderlund C, Wahren J. Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis. Scand J Gastroenterol 1987; 22: 919-25. [CrossRef] 6. Erbas T, Usman A, Erbas B, Varoglu E, Aras T, Bekdik C. Short-term effects of somatostatin analogue (SMS 201-995) on left ventricular function in healthy persons: a scintigraphic study. J Endocrinol Invest 1993; 16: 857-61. [CrossRef] 7. Baik SK, Jeong PH, Ji SW, et al. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison. Am J Gastroenterol 2005; 100: 631-5. [CrossRef] 8. McCormick PA, Chin J, Greenslade L, et al. Cardiovascular effects of octreotide in patients with hepatic cirrhosis. Hepatology 1995; 21: 1255-60. [CrossRef] 9. Katz MD, Erstad BL. Octreotide, a new somatostatin analogue. Clin Pharm 1989; 8: 255-73
  3. Herrington AM, George KW, Moulds CC. Octreotide-induced bradycardia. Pharmacotherapy 1998; 18: 413-6
  4. Tuncer M, Gümrükçüoğlu HA, Mete R, Güneş Y, Güntekin U. A case of complete heart block induced by octreotide. Turk J Gastroenterol 2010; 21: 72-3. [CrossRef]